Private equity firm Keensight Capital is in negotiations with Reed Elsevier for the sale of FircoSoft, a specialist in watch list filtering solutions. The proposed transaction is expected to be concluded in the coming weeks, pending the completion of a consultation with the works council of FircoSoft. Created in
Cressey & Company and Level Equity Management have sold Strategic Healthcare Programs (SHP) to Roper Industries, a diversified technology company. SHP, headquartered in Santa Barbara, California, is a provider of software and informatics solutions to the post-acute healthcare market. SHP delivers data-driven insight to thousands of post-acute organisations, such as home
Edmond De Rothschild Investment Partners’s (EdRIP) BioDiscovery 3 portfolio company, Covagen AG, has been acquired by Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Company. Covagen is a privately-held, biopharmaceutical company specialising in the development of multi-specific protein therapeutics through the FynomAb technology platform. The company's lead product, COVA322,
2013 was a year of strong private equity exit activity in the Central and Eastern Europe (CEE) region, the third highest on record, according to the European Private Equity and Venture Capital Association (EVCA). Unlike the previous two record years, 2013 was not dominated by one or two large disposals.
D5 Capital, the media and technology investment and M&A advisor, has secured a cash exit from WalkMe, the interactive online guidance and engagement platform. D5 Capital’s investor network and super-angel Ran Tushia participated in WalkMe’s Series A investment round in 2012. The exit has delivered investors a 3.5x gain
Arlington Capital Partners has sold Virgo Holdings, an integrated business-to-business information services company, to Informa plc. Headquartered in Phoenix, Arizona, Virgo is focused on delivering content within the fast-growing natural products, communications, healthcare and business solutions industries via live events, electronic and print media products, and online platforms. Currently, Virgo
Private equity firm ClearLight Partners has sold portfolio company Apple & Eve to Lassonde Industries for a total cash consideration of USD150 million, subject to adjustments for working capital and other items. Founded in 1975, Port Washington, NY-based Apple & Eve is the largest privately held producer of 100% fruit
Investcorp, a provider and manager of alternative investment products, has completed the sale of SourceMedia to Observer Capital. Terms of the transaction have not been disclosed. Investcorp originally acquired SourceMedia, inclusive of its Accuity affiliate, from the Thomson Corporation in 2004. Through Investcorp's stewardship, SourceMedia made significant investments and changes
The sale of two portfolio companies – Precision Dermatology, and CardioMEMS – has seen the limited partners of private equity firm Boston Millennia Partners realise USD10.5 million. With the receipt of Hart-Scott-Rodino clearance, the acquisition of Precision Dermatology by Valeant Pharmaceuticals, for USD500 million, closed on 7 July. On
Beringea’s portfolio company Altacor has been acquired by Esperante, a Netherlands-based life science investment company, for an undisclosed sum. Beringea first invested in Altacor in 2007. Altacor is a specialty ophthalmology company with a portfolio of eight marketed pharmaceutical products. The company differentiates its development products primarily through formulation
12 September, 2024 – 6:00 pm
05 June, 2024 – 8:30 am
24 October, 2024 – 8:30 am
14 November, 2024 – 8:00 am
